A review posted in JAMA Network Open emphasizes the discrepancy concerning what it costs to produce copyright plus the retail selling prices people encounter. Regardless of the minimal creation expenditures, Novo Nordisk hasn't publicly disclosed specific figures for copyright or its other merchandise, Wegovy.The subsequent table lists a number of